Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement-Reference-Cited by-同舟云学术

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement

Published:2014-04-30 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ueta Mayumi,Kaniwa Nahoko,Sotozono Chie,Tokunaga Katsushi,Saito Yoshiro,Sawai Hiromi,Miyadera Hiroko,Sugiyama Emiko,Maekawa Keiko,Nakamura Ryosuke,Nagato Masaki,Aihara Michiko,Matsunaga Kayoko,Takahashi Yukitoshi,Furuya Hirokazu,Muramatsu Masaaki,Ikezawa Zenrou,Kinoshita Shigeru

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep04862.pdf

Reference28 articles.

1. Ueta, M. et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 91, 962–965 (2007).

2. Yamane, Y., Aihara, M. & Ikezawa, Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int 56, 419–425 (2007).

3. Yetiv, J. Z., Bianchine, J. R. & Owen, J. A., Jr Etiologic factors of the Stevens-Johnson syndrome. South Med J 73, 599–602 (1980).

4. Roujeau, J. C. et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333, 1600–1607 (1995).

5. Chan, H. L. et al. The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 126, 43–47 (1990).

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Phenotype of HLA B*44 Patients in a Rheumatology Outpatient Clinic Favors Peripheral Arthropathies;Journal of Clinical Medicine;2024-09-13

2. Ocular involvement in Steven-Johnson syndrome/toxic epidermal necrolysis: recent insights into pathophysiology, biomarkers, and therapeutic strategies;Current Opinion in Ophthalmology;2024-08-13

3. Ocular Manifestations and Outcomes in Children With Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison With Adult Patients;American Journal of Ophthalmology;2023-12

4. Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions;Frontiers in Pharmacology;2023-09-19

5. Eyelid and Vaginal Adhesions as Severe Sequelae of Toxic Epidermal Necrolysis;Cureus;2023-07-07